SLC1A2 | Solute carrier family 1 (glial high affinity glutamate transporter), member 2 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC1A3 | Solute carrier family 1 (glial high affinity glutamate transporter), member 3 | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC1A6 | Solute carrier family 1 (high affinity aspartate/glutamate transporter), member 6 | Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC20A2 | Solute carrier family 20 (phosphate transporter), member 2 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC22A13 | Solute carrier family 22 (organic anion/urate transporter), member 13 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC22A16 | Solute carrier family 22 (organic cation/carnitine transporter), member 16 | Predicted membrane proteins
| | | | | Group enriched |
SLC22A2 | Solute carrier family 22 (organic cation transporter), member 2 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC22A8 | Solute carrier family 22 (organic anion transporter), member 8 | FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC23A1 | Solute carrier family 23 (ascorbic acid transporter), member 1 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC26A3 | Solute carrier family 26 (anion exchanger), member 3 | Cancer-related genes Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC26A6 | Solute carrier family 26 (anion exchanger), member 6 | Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC28A1 | Solute carrier family 28 (concentrative nucleoside transporter), member 1 | Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC28A2 | Solute carrier family 28 (concentrative nucleoside transporter), member 2 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC2A1 | Solute carrier family 2 (facilitated glucose transporter), member 1 | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC2A2 | Solute carrier family 2 (facilitated glucose transporter), member 2 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC2A3 | Solute carrier family 2 (facilitated glucose transporter), member 3 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC2A4 | Solute carrier family 2 (facilitated glucose transporter), member 4 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC2A9 | Solute carrier family 2 (facilitated glucose transporter), member 9 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC32A1 | Solute carrier family 32 (GABA vesicular transporter), member 1 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC35D2 | Solute carrier family 35 (UDP-GlcNAc/UDP-glucose transporter), member D2 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC37A1 | Solute carrier family 37 (glucose-6-phosphate transporter), member 1 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC37A4 | Solute carrier family 37 (glucose-6-phosphate transporter), member 4 | Predicted membrane proteins
| | | | | Expressed in all |
SLC38A10 | Solute carrier family 38, member 10 | Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC41A2 | Solute carrier family 41 (magnesium transporter), member 2 | Predicted membrane proteins Transporters
| | | | | Mixed |
SLC43A1 | Solute carrier family 43 (amino acid system L transporter), member 1 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC43A2 | Solute carrier family 43 (amino acid system L transporter), member 2 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC44A4 | Solute carrier family 44, member 4 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Mixed |
SLC45A3 | Solute carrier family 45, member 3 | Cancer-related genes Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC4A1 | Solute carrier family 4 (anion exchanger), member 1 (Diego blood group) | Blood group antigen proteins CD markers Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC4A2 | Solute carrier family 4 (anion exchanger), member 2 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC4A4 | Solute carrier family 4 (sodium bicarbonate cotransporter), member 4 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC4A7 | Solute carrier family 4, sodium bicarbonate cotransporter, member 7 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC5A1 | Solute carrier family 5 (sodium/glucose cotransporter), member 1 | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC5A2 | Solute carrier family 5 (sodium/glucose cotransporter), member 2 | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC5A5 | Solute carrier family 5 (sodium/iodide cotransporter), member 5 | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC6A1 | Solute carrier family 6 (neurotransmitter transporter), member 1 | FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC6A18 | Solute carrier family 6 (neutral amino acid transporter), member 18 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC6A6 | Solute carrier family 6 (neurotransmitter transporter), member 6 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC7A1 | Solute carrier family 7 (cationic amino acid transporter, y+ system), member 1 | Predicted membrane proteins Transporters
| | | | | Mixed |
SLC7A9 | Solute carrier family 7 (amino acid transporter light chain, bo,+ system), member 9 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC8A1 | Solute carrier family 8 (sodium/calcium exchanger), member 1 | FDA approved drug targets Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enhanced |
SLC9A1 | Solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC9A3 | Solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 | Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC9A5 | Solute carrier family 9, subfamily A (NHE5, cation proton antiporter 5), member 5 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLCO1B3 | Solute carrier organic anion transporter family, member 1B3 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLCO6A1 | Solute carrier organic anion transporter family, member 6A1 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SPNS1 | Spinster homolog 1 (Drosophila) | Mitochondrial proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
STT3A | STT3A, subunit of the oligosaccharyltransferase complex (catalytic) | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
SV2A | Synaptic vesicle glycoprotein 2A | FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enriched |
TMEM63B | Transmembrane protein 63B | Predicted membrane proteins Transporters
| | | | | Expressed in all |